文献
J-GLOBAL ID:201802249285026220
整理番号:18A0504058
「抗プログラム細胞死蛋白質1抗体が誘導する」劇症1型糖尿病では抗プログラム細胞死蛋白質1抗体による治療を中止することで内因性インスリン分泌能力が保存される可能性がある
Intrinsic insulin secretion capacity might be preserved by discontinuing anti-programmed cell death protein 1 antibody treatment in ‘anti-programmed cell death protein 1 antibody-induced’ fulminant type 1 diabetes
著者 (10件):
Sakai Gota
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Saito Daigo
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Nakajima Ritsuko
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Hatano Masako
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Noguchi Yuichi
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Kurihara Susumu
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Katayama Shigehiro
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Inoue Ikuo
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Noda Mitsuhiko
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
,
Shimada Akira
(Department of Endocrinology and Diabetes, Saitama Medical University, Moroyama, Iruma Saitama, Japan)
資料名:
Journal of Diabetes Investigation (Web)
(Journal of Diabetes Investigation (Web))
巻:
9
号:
2
ページ:
448-449
発行年:
2018年
JST資料番号:
U0507A
ISSN:
2040-1124
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)